Acting FTC chairman says deal with China with carrots and sticks
Acting FTC Chair Maureen Ohlhausen says the U.S. has to point out the bad and recognize the good in antitrust issues with China.
Shire Rejects $46B AbbVie Offer
The proposal followed two other pitches from AbbVie, which wants to move its tax domicile to the U.K.
Shire Quickly Pulls Off Dermagraft
Irish pharmaceuticals company Shire said on Friday it had arranged to hand its Dermagraft skin substitute to Organogenesis and take a $650 million loss on the disposal, which unwinds a major part of an acquisition it made less than three years ago.
Market Up on Deals, Results
Markets edged higher as some stocks jumped on deal making, with key retailer results to be closely watched this week.
Shire Deal Just The Start
Shire's purchase of ViroPharma is a signal of deals and higher prices ahead, says Jason Kolbert, Sr. Research Analyst at the Maxim Group.
Ford Makes a Major Change
The legacy automaker has just made a decision that will affect consumers buying its electric vehicles via a lease.
Tesla Q2 Deliveries Slump To 254,695 As Shanghai Shutdown, Supply Chain Snarls Take Toll
Tesla said it had a record rate of production in June, but supply chain disruption and the closure of its Shanghai gigafactory triggered a slump in Q2 deliveries.
Coinbase Faces A New Scandal
The platform denies selling proprietary customer data and announces it is expanding into several European countries.